Welcome to our dedicated page for WELLS FARGO & COMPANY/MN SEC filings (Ticker: WFCNP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on WELLS FARGO & COMPANY/MN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into WELLS FARGO & COMPANY/MN's regulatory disclosures and financial reporting.
Wells Fargo & Company director Steven D. Black reported a compensation-related grant of 1,076.3324 Phantom Stock Units. These units were awarded at a reference price of $85.94 per unit and each unit represents the right to receive one share of Wells Fargo common stock.
Following this award and related dividend equivalents, Black now holds 58,079.1554 Phantom Stock Units as deferred compensation, payable in a lump sum or installments based on his prior election. A separate line shows 140.7669 shares of common stock held directly, including shares acquired through a dividend reinvestment program.
Wells Fargo & Company executive Jason M. Rosenberg, SEVP & Head of Public Affairs, reported equity compensation activity involving restricted share rights. On June 15, 2026, 17,217.8038 Restricted Share Rights vested into an equal number of common shares. To cover tax obligations, 8,079.4933 common shares were disposed of through share withholding rather than an open-market sale. After these transactions, Rosenberg directly holds 21,569.8560 shares of Wells Fargo common stock. The vested award represents the remaining half of a grant originally made on June 25, 2024, including dividend equivalents, and is subject to the company’s stock ownership policy.
Wells Fargo & Company reported issuing new Medium-Term Notes, Series Y, under its shelf Registration Statement on Form S-3. The bank sold $2,250,000,000 of Senior Redeemable Fixed-to-Floating Rate Notes due May 20, 2029 and $500,000,000 of Senior Redeemable Floating Rate Notes due the same date.
It also issued $3,250,000,000 of Senior Redeemable Fixed-to-Floating Rate Notes due May 20, 2032. The filing mainly places into the record the forms of these notes and a legal opinion from Faegre Drinker Biddle & Reath LLP confirming the validity of the securities.
Wells Fargo & Company director Theodore F. Craver Jr. reported gifting a total of 178 shares of Common Stock, $1 2/3 par value, on May 14, 2026. The Form 4 shows two bona fide gifts of 89 shares each from indirect and direct holdings.
After these gifts, Craver Jr. reports 27,201 shares held indirectly through a revocable trust, 6,000 shares held indirectly through an irrevocable trust, and no directly held shares remaining.
Wells Fargo & Company filed a Form 13F reporting institutional holdings managed by the firm and six other included managers. The report lists 17,971 Form 13F information table entries with a total value of $530,336,323,912 (rounded). The report is signed by Patricia Arce on 05-11-2026.
Wells Fargo & Company director Suzanne M. Vautrinot received a grant of 3,436 Common Stock Units as compensation. Each unit represents the right to receive one share of Wells Fargo common stock. The units vested upon grant, with settlement deferred until after her service as a director ends or a later elected date.
Following this award, she holds 17,851.9647 Common Stock Units directly, 5,508.3921 shares of common stock directly, and 12,129 shares indirectly through a trust. The indirect holdings include shares acquired under a dividend reinvestment program and dividend equivalents reinvested in additional Common Stock Units.
SARGENT RONALD reported acquisition or exercise transactions in this Form 4 filing.
Wells Fargo & Company director Ronald Sargent received a compensation grant of 3,436 Common Stock Units. Each unit represents the right to receive one share of Wells Fargo common stock. The units vested immediately on grant, but settlement is deferred until he leaves the board or a later elected date.
Following this grant, Sargent holds 17,851.9647 Common Stock Units directly, 18,050 shares of common stock indirectly through a revocable trust, and 81 shares directly. The Common Stock Units balance also includes dividend equivalents that have been reinvested in additional units.
Norwood Felicia F reported acquisition or exercise transactions in this Form 4 filing.
Wells Fargo & Company director Felicia F. Norwood received a grant of 3,436 Common Stock Units, each representing one share of Wells Fargo common stock. The units vested upon grant, but settlement is deferred until at least her termination of service as a director or a later elected date, and include dividend equivalents reinvested in additional units.
After this grant, she directly holds 17,851.9647 Common Stock Units, along with direct holdings of common stock and several series of Wells Fargo preferred shares.
Morris Maria R reported acquisition or exercise transactions in this Form 4 filing.
Wells Fargo & Company director Maria R. Morris received a compensation-related equity award. She was granted 3,436 Common Stock Units on Company stock at a reference price of $81.50 per unit. Each unit represents the right to receive one share of common stock.
The Common Stock Units vested upon grant, but settlement is deferred until the later of her termination of service as a director or a later settlement date she elects. Following this award, her deferred Common Stock Unit balance is 17,851.9647 units, and she directly holds 4,253 shares of common stock.
Morken CeCelia reported acquisition or exercise transactions in this Form 4 filing.
Wells Fargo & Company director CeCelia Morken reported a compensation-related equity grant. She received 3,436 Common Stock Units at a reference price of $81.50 per unit, with each unit representing the right to receive one share of Wells Fargo common stock.
The units vested upon grant, but settlement is deferred until the later of her termination of service as a director or a later date she elected. The total Common Stock Units credited to her account after this grant is 17,851.9647, including dividend equivalents reinvested in additional units. She also holds 100 shares of Wells Fargo common stock directly.